Protocol Development and Quality Improvement

Intervention Type

Consult Pharmacy Dosing

Order Clarification

Allergy

Drug Interaction

Non-Formulary

Duplicate Therapy

IV to PO

Emergency Response

Medication Reconcilliation

Drug Monitoring

Dose Check

Discontinue/Switch Drug

Other

Intervention Type

Quarterly Cost Avoidance

$800,000

$600,000

$400,000

$200,000

$0

1st Quarter

2nd Quarter

3rd Quarter

4th Quarter

Cost Avoidance

$477,867

$681,978

$652,145

$701,542

previous years (Figure 5) and the cost savings with previous years (Figure 6) and in providing rational

explanations for any discrepancies noted.

in number of pharmacists, implementation of guidelines/protocols to standardize care, etc., may impact

these numbers and should be considered when assessing.

patient safety and cost savings. Examples of high-priority pharmacotherapeutic interventions that should be

reported include the following:

Allergy prevented

Drug dosing adjustments

Duplicate therapy avoided

Drug interactions avoided

Medication reconciliation intervention

Ordering laboratory tests for monitoring of drug safety and efficacy

Switching drug for less expensive but equally safe and effective drug